» Articles » PMID: 18263800

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

Overview
Specialty Critical Care
Date 2008 Feb 12
PMID 18263800
Citations 210
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Pulmonary infection in cystic fibrosis (CF) is polymicrobial and it is possible that anaerobic bacteria, not detected by routine aerobic culture methods, reside within infected anaerobic airway mucus.

Objectives: To determine whether anaerobic bacteria are present in the sputum of patients with CF.

Methods: Sputum samples were collected from clinically stable adults with CF and bronchoalveolar lavage fluid (BALF) samples from children with CF. Induced sputum samples were collected from healthy volunteers who did not have CF. All samples were processed using anaerobic bacteriologic techniques and bacteria within the samples were quantified and identified.

Measurements And Main Results: Anaerobic species primarily within the genera Prevotella, Veillonella, Propionibacterium, and Actinomyces were isolated in high numbers from 42 of 66 (64%) sputum samples from adult patients with CF. Colonization with Pseudomonas aeruginosa significantly increased the likelihood that anaerobic bacteria would be present in the sputum. Similar anaerobic species were identified in BALF from pediatric patients with CF. Although anaerobes were detected in induced sputum samples from 16 of 20 volunteers, they were present in much lower numbers and were generally different species compared with those detected in CF sputum. Species-dependent differences in the susceptibility of the anaerobes to antibiotics with known activity against anaerobes were apparent with all isolates susceptible to meropenem.

Conclusions: A range of anaerobic species are present in large numbers in the lungs of patients with CF. If these anaerobic bacteria are contributing significantly to infection and inflammation in the CF lung, informed alterations to antibiotic treatment to target anaerobes, in addition to the primary infecting pathogens, may improve management.

Citing Articles

Clinical relevance of lung microbiota composition in critically ill children with acute lower respiratory tract infections: insights from a retrospective analysis of metagenomic sequencing.

Men Z, Chen Z, Gu X, Wang Y, Zhang X, Fang F Eur J Clin Microbiol Infect Dis. 2024; 44(1):83-98.

PMID: 39520618 PMC: 11739189. DOI: 10.1007/s10096-024-04980-y.


Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung-Gut Axis and Beyond.

Mazumder M, Hussain S J Xenobiot. 2024; 14(4):1595-1612.

PMID: 39449427 PMC: 11503347. DOI: 10.3390/jox14040086.


Clarithromycin Modulates Neutrophilic Inflammation Induced by in Human Airway Epithelial Cells.

Iwanaga N, Ota A, Ashizawa H, Ito Y, Hirayama T, Yoshida M Antibiotics (Basel). 2024; 13(9).

PMID: 39335081 PMC: 11429484. DOI: 10.3390/antibiotics13090909.


Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.

Saiman L, Waters V, LiPuma J, Hoffman L, Alby K, Zhang S Clin Microbiol Rev. 2024; 37(3):e0021521.

PMID: 39158301 PMC: 11391703. DOI: 10.1128/cmr.00215-21.


Understanding bacterial diversity, infection dynamics, prevention of antibiotic resistance: an integrated study in an Algerian hospital context.

Adouane M, Kadri N, Benzitoune N, Lakhdari C, Djellal S, Ousmer L Eur J Clin Microbiol Infect Dis. 2024; 43(11):2093-2105.

PMID: 39136832 DOI: 10.1007/s10096-024-04919-3.